UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Increased Incidence of Gestational Diabetes in Women Receiving Prophylactic 17α-Hydroxyprogesterone Caproate for Prevention of Recurrent Preterm Delivery

Diabetes care, 2007-09, Vol.30 (9), p.2277-2280

2007

Volltextzugriff (PDF)

Impact of Glycemic Control on Neonatal Outcome in Singleton Pregnancies Complicated by Gestational Diabetes

Diabetes care, 2007-03, Vol.30 (3), p.467-470

2007

Volltextzugriff (PDF)

Pregnancy outcomes of women receiving compounded 17 α-hydroxyprogesterone caproate for prophylactic prevention of preterm birth 2004 to 2011

American journal of perinatology, 2012-09, Vol.29 (8), p.635-642

2012

Volltextzugriff (PDF)

Influence of gestational age and reason for prior preterm birth on rates of recurrent preterm delivery

American journal of obstetrics and gynecology, 2011-09, Vol.205 (3), p.275.e1-275.e5

2011

Volltextzugriff (PDF)

Maternal Characteristics Influencing the Development of Gestational Diabetes in Obese Women Receiving 17-alpha-Hydroxyprogesterone Caproate

Journal of Obesity, 2014-01, Vol.2014 (2014), p.an1-4

2014

Volltextzugriff (PDF)

Prophylaxis with 17 alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery: does gestational age at initiation of treatment matter?

American journal of obstetrics and gynecology, 2007-09, Vol.197 (3), p.260.e1-260.e4

2007

Volltextzugriff (PDF)

Increased recurrence of preterm delivery with early cessation of 17-alpha-hydroxyprogesterone caproate

American journal of obstetrics and gynecology, 2007-03, Vol.196 (3), p.224.e1-224.e4

2007

Volltextzugriff (PDF)

Elective delivery at 340/7 to 366/7 weeks' gestation and its impact on neonatal outcomes in women with stable mild gestational hypertension

American journal of obstetrics and gynecology, 2011, Vol.204 (1), p.44.e1-44.e5

2011

Volltextzugriff (PDF)

Antenatal factors predicting subsequent need for insulin treatment in women with gestational diabetes

Journal of women's health (Larchmont, N.Y. 2002), 2008-09, Vol.17 (7), p.1183-1187

2008

Volltextzugriff (PDF)

Management of recurrent preterm labor in twin gestations with nifedipine tocolysis

American journal of perinatology, 2008-10, Vol.25 (9), p.555-560

2008

Volltextzugriff (PDF)

Uterine activity in women receiving 17 alpha-hydroxyprogesterone caproate for the prevention of preterm birth: an observational study

American journal of perinatology, 2010-02, Vol.27 (2), p.157-162

2010

Volltextzugriff (PDF)

The reliability of patient-reported pregnancy outcome data

Population health management, 2010-02, Vol.13 (1), p.27-32

2010

Volltextzugriff (PDF)

Using 17 α-hydroxyprogesterone caproate to impact rates of recurrent preterm delivery in clinical practice

The journal of maternal-fetal & neonatal medicine, 2010-10, Vol.23 (10), p.1139-1142

2010

Volltextzugriff (PDF)

Clinical characteristics of women prescribed 17 alpha-hydroxyprogesterone caproate in the community setting

American journal of obstetrics and gynecology, 2007-09, Vol.197 (3), p.262.e1-262.e4

2007

Volltextzugriff (PDF)

Preterm birth prevention by 17 alpha-hydroxyprogesterone caproate vs. daily nursing surveillance

Journal of reproductive medicine, 2009-02, Vol.54 (2), p.47

2009

Volltextzugriff (PDF)

The impact of acute tocolysis on neonatal outcome in women hospitalized with preterm labor at 32 to 34 weeks' gestation

American journal of perinatology, 2009-02, Vol.26 (2), p.123-128

2009

Volltextzugriff (PDF)

Women receiving 17-α-hydroxyprogesterone caproate hospitalized for preterm labor at less than 34 weeks benefit from daily perinatal nursing surveillance

American journal of obstetrics and gynecology, 2008-10, Vol.199 (4), p.389.e1-389.e4

2008

Volltextzugriff (PDF)

A Randomized Multicenter Study to Determine the Efficacy of Activity Restriction for Preterm Labor Management in Patients Testing Negative for Fetal Fibronectin

Journal of Perinatology, 2005-10, Vol.25 (10), p.626-630

2005

Volltextzugriff (PDF)

Antepartum uterine contraction patterns in twin pregnancies with and without preterm labor and delivering before or after 36 weeks

American journal of obstetrics and gynecology, 2008-05, Vol.198 (5), p.e28-e29

2008

Volltextzugriff (PDF)

Home uterine activity monitoring: the role of medical evidence

Obstetrics and gynecology (New York. 1953), 2008-12, Vol.112 (6), p.1389

2008

Volltextzugriff (PDF)

Increased Incidence of Gestational Diabetes in Women Receiving Prophylactic 17α-Hydroxyprogesterone Caproate for Prevention of Recurrent Preterm Delivery

Obstetrical & gynecological survey, 2008-02, Vol.63 (2), p.72-74

2008

Volltextzugriff (PDF)

The impact of maternal obesity on the incidence of adverse pregnancy outcomes in high-risk term pregnancies

American journal of perinatology, 2009-05, Vol.26 (5), p.345-349

2009

Volltextzugriff (PDF)

Adverse pregnancy outcomes in women with nausea and vomiting of pregnancy

The journal of maternal-fetal & neonatal medicine, 2014-01, Vol.27 (1), p.84-88

2014

Volltextzugriff (PDF)

Gestational age at initiation of 17-hydroxyprogesterone caproate (17P) and recurrent preterm delivery

The journal of maternal-fetal & neonatal medicine, 2007-03, Vol.20 (3), p.249-252

2007

Volltextzugriff (PDF)

833: Should gestational weight loss be encouraged for obese women?

American journal of obstetrics and gynecology, 2012, Vol.206 (1), p.S365-S365

2012

Volltextzugriff (PDF)

1 – 25 von 130

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(123)
Mit Volltextzugriff
(78)

Publikationsform

Artikel
(127)
magazinearticle
(3)

Sprache

Englisch
(130)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Increased Incidence of Gestational Diabetes in Women Receiving Prophylactic 17α-Hydroxyprogesterone Caproate for Prevention of Recurrent Preterm Delivery

Impact of Glycemic Control on Neonatal Outcome in Singleton Pregnancies Complicated by Gestational Diabetes

Pregnancy outcomes of women receiving compounded 17 α-hydroxyprogesterone caproate for prophylactic prevention of preterm birth 2004 to 2011

Influence of gestational age and reason for prior preterm birth on rates of recurrent preterm delivery

Maternal Characteristics Influencing the Development of Gestational Diabetes in Obese Women Receiving 17-alpha-Hydroxyprogesterone Caproate

Prophylaxis with 17 alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery: does gestational age at initiation of treatment matter?

Increased recurrence of preterm delivery with early cessation of 17-alpha-hydroxyprogesterone caproate

Elective delivery at 340/7 to 366/7 weeks' gestation and its impact on neonatal outcomes in women with stable mild gestational hypertension

Antenatal factors predicting subsequent need for insulin treatment in women with gestational diabetes

Management of recurrent preterm labor in twin gestations with nifedipine tocolysis

Uterine activity in women receiving 17 alpha-hydroxyprogesterone caproate for the prevention of preterm birth: an observational study

The reliability of patient-reported pregnancy outcome data

Using 17 α-hydroxyprogesterone caproate to impact rates of recurrent preterm delivery in clinical practice

Clinical characteristics of women prescribed 17 alpha-hydroxyprogesterone caproate in the community setting

Preterm birth prevention by 17 alpha-hydroxyprogesterone caproate vs. daily nursing surveillance

The impact of acute tocolysis on neonatal outcome in women hospitalized with preterm labor at 32 to 34 weeks' gestation

Women receiving 17-α-hydroxyprogesterone caproate hospitalized for preterm labor at less than 34 weeks benefit from daily perinatal nursing surveillance

A Randomized Multicenter Study to Determine the Efficacy of Activity Restriction for Preterm Labor Management in Patients Testing Negative for Fetal Fibronectin

Antepartum uterine contraction patterns in twin pregnancies with and without preterm labor and delivering before or after 36 weeks

Home uterine activity monitoring: the role of medical evidence

Increased Incidence of Gestational Diabetes in Women Receiving Prophylactic 17α-Hydroxyprogesterone Caproate for Prevention of Recurrent Preterm Delivery

The impact of maternal obesity on the incidence of adverse pregnancy outcomes in high-risk term pregnancies

Adverse pregnancy outcomes in women with nausea and vomiting of pregnancy

Gestational age at initiation of 17-hydroxyprogesterone caproate (17P) and recurrent preterm delivery

833: Should gestational weight loss be encouraged for obese women?

Suchergebnisse filtern